Sodium‐glucose cotransporter 2 inhibitiors and death from any cause in a real world setting

Mar-17

AUTHORS : Dr Krishnarajah Nirantharakumar, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK – E-mail: k.nirantharan@bham.ac.uk – Profile: https://www.birmingham.ac.uk/staff/profiles/applied-health/nirantharakumar-krishnarajah.aspx OR Dr Konstantinos A Toulis, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK / Department of Endocrinology, 424 General Military Hospital, Thessaloniki- Email: K.Toulis@bham.ac.uk – Profile (European Foundatio for the Study of Diabetes): http://www.europeandiabetesfoundation.org/konstantinos-toulis.html

JOURNAL : Diabetic Medicine

REFERENCE: 34(S1):160

DOI : 10.1111/dme.37_13304

Sodium‐glucose cotransporter 2 inhibitiors and death from any cause in a real world setting

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study